SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 95.10 |
| Enterprise Value ($M) | 137.09 |
| Book Value ($M) | -40.36 |
| Book Value / Share | -3.99 |
| Price / Book | -2.36 |
| NCAV ($M) | -84.66 |
| NCAV / Share | -8.36 |
| Price / NCAV | -1.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.45 |
| Current Ratio | 0.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 84.48 |
| Assets | 128.78 |
| Liabilities | 169.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 78.23 |
| Operating Income | -16.32 |
| Net Income | -21.54 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -44.68 |
| Cash from Investing | -0.07 |
| Cash from Financing | 55.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Kingdon Capital Management, L.l.c. | 5.10 | ||
| 13G/A | Nantahala Capital Management, LLC | 9.99 | ||
| 13G/A | Great Point Partners Llc | 8.47 | ||
| 13G/A | Stonepine Capital Management, LLC | 5.90 | ||
| 13G/A | Rosalind Advisors, Inc. | 8.70 | ||
| 13G/A | Fmr Llc | 12.21 | 11.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,085 | 20,541 | 5.28 | |
| 324 | 7,136 | 4.54 | |
| 260 | 22,596 | 1.15 | |
| 3,840 | 20,101 | 19.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OGI – Organigram Global Inc. | OLMA – Olema Pharmaceuticals, Inc. |
| OPK – OPKO Health, Inc. | ORIC – ORIC Pharmaceuticals, Inc. |
| OVID – Ovid Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io